This, in turn, upregulates the synthesis of other arginine transporters, such as SLC1A3 and SLC7A2, which compensate for glutamine deficiency and promote GBM cell survival by activating the mTOR pathway (Xu et al. 2023). The gene discussed is SLC1A3; the disease is glioblastoma.